APO Research

APO RESEARCH · REPORT

Enzymes for β-lactam Antibiotics

Selected research

Market Structure

Global Enzymes for β-lactam Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Enzymes for β-lactam Antibiotics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Enzymes for β-lactam Antibiotics include MCE, Amicogen, Biosynth, Crawford Wisdom International, Creative Enzymes, Fermenta Biotech Ltd., Merck & Co., MuseChem Chemicals and Biolab, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Enzymes for β-lactam Antibiotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enzymes for β-lactam Antibiotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enzymes for β-lactam Antibiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enzymes for β-lactam Antibiotics market size, projected growth trends, production technologies, key applications, and end-use industries.

Enzymes for β-lactam Antibiotics Segment by Company

MCE

Amicogen

Biosynth

Crawford Wisdom International

Creative Enzymes

Fermenta Biotech Ltd.

Merck & Co.

MuseChem Chemicals

Biolab

Hangzhou Chuangke Biotech

Hangzhou Junfeng Bioengineering

Hunan Fulaige Biotech

Shanghai Kekai Biotech

Enzymes for β-lactam Antibiotics Segment by Type

Penicillin Acylase

β-lactamase

Other

Enzymes for β-lactam Antibiotics Segment by Application

Cephalosporins

Penicillin and Its Derivatives

Monoamide Ring

Other

Enzymes for β-lactam Antibiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzymes for β-lactam Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzymes for β-lactam Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzymes for β-lactam Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Enzymes for β-lactam Antibiotics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Enzymes for β-lactam Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Enzymes for β-lactam Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Enzymes for β-lactam Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Enzymes for β-lactam Antibiotics Industry Trends Table 2. Enzymes for β-lactam Antibiotics Industry Drivers Table 3. Enzymes for β-lactam Antibiotics Industry Opportunities and Challenges Table 4. Enzymes for β-lactam Antibiotics Industry Restraints Table 5. Global Enzymes for β-lactam Antibiotics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Enzymes for β-lactam Antibiotics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Enzymes for β-lactam Antibiotics Sales Market Share by Manufacturers Table 9. Global Enzymes for β-lactam Antibiotics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Enzymes for β-lactam Antibiotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Enzymes for β-lactam Antibiotics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Enzymes for β-lactam Antibiotics Manufacturers, Product Type & Application Table 13. Global Enzymes for β-lactam Antibiotics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Enzymes for β-lactam Antibiotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Penicillin Acylase Table 17. Major Manufacturers of β-lactamase Table 18. Major Manufacturers of Other Table 19. Global Enzymes for β-lactam Antibiotics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Enzymes for β-lactam Antibiotics Sales by Type (2021-2026) & (K Units) Table 21. Global Enzymes for β-lactam Antibiotics Sales by Type (2027-2032) & (K Units) Table 22. Global Enzymes for β-lactam Antibiotics Sales Market Share by Type (2021-2026) Table 23. Global Enzymes for β-lactam Antibiotics Sales Market Share by Type (2027-2032) Table 24. Global Enzymes for β-lactam Antibiotics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Enzymes for β-lactam Antibiotics Revenue by Type (2021-2026) & (K Units) Table 26. Global Enzymes for β-lactam Antibiotics Revenue by Type (2027-2032) & (K Units) Table 27. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Type (2021-2026) Table 28. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Cephalosporins Table 30. Major Manufacturers of Penicillin and Its Derivatives Table 31. Major Manufacturers of Monoamide Ring Table 32. Major Manufacturers of Other Table 33. Global Enzymes for β-lactam Antibiotics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Enzymes for β-lactam Antibiotics Sales by Application (2021-2026) & (K Units) Table 35. Global Enzymes for β-lactam Antibiotics Sales by Application (2027-2032) & (K Units) Table 36. Global Enzymes for β-lactam Antibiotics Sales Market Share by Application (2021-2026) Table 37. Global Enzymes for β-lactam Antibiotics Sales Market Share by Application (2027-2032) Table 38. Global Enzymes for β-lactam Antibiotics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Enzymes for β-lactam Antibiotics Revenue by Application (2021-2026) & (K Units) Table 40. Global Enzymes for β-lactam Antibiotics Revenue by Application (2027-2032) & (K Units) Table 41. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Application (2021-2026) Table 42. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Application (2027-2032) Table 43. Global Enzymes for β-lactam Antibiotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Enzymes for β-lactam Antibiotics Sales by Region (2021-2026) & (K Units) Table 45. Global Enzymes for β-lactam Antibiotics Sales Market Share by Region (2021-2026) Table 46. Global Enzymes for β-lactam Antibiotics Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Enzymes for β-lactam Antibiotics Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Enzymes for β-lactam Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Enzymes for β-lactam Antibiotics Sales by Country (2021-2026) & (K Units) Table 50. North America Enzymes for β-lactam Antibiotics Sales by Country (2027-2032) & (K Units) Table 51. Europe Enzymes for β-lactam Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Enzymes for β-lactam Antibiotics Sales by Country (2021-2026) & (K Units) Table 53. Europe Enzymes for β-lactam Antibiotics Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Enzymes for β-lactam Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Enzymes for β-lactam Antibiotics Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Enzymes for β-lactam Antibiotics Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Enzymes for β-lactam Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Enzymes for β-lactam Antibiotics Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Enzymes for β-lactam Antibiotics Sales by Country (2027-2032) & (K Units) Table 60. Global Enzymes for β-lactam Antibiotics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Enzymes for β-lactam Antibiotics Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Enzymes for β-lactam Antibiotics Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Region (2021-2026) Table 64. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Region (2027-2032) Table 65. MCE Company Information Table 66. MCE Business Overview Table 67. MCE Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. MCE Enzymes for β-lactam Antibiotics Product Portfolio Table 69. MCE Recent Development Table 70. Amicogen Company Information Table 71. Amicogen Business Overview Table 72. Amicogen Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Amicogen Enzymes for β-lactam Antibiotics Product Portfolio Table 74. Amicogen Recent Development Table 75. Biosynth Company Information Table 76. Biosynth Business Overview Table 77. Biosynth Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Biosynth Enzymes for β-lactam Antibiotics Product Portfolio Table 79. Biosynth Recent Development Table 80. Crawford Wisdom International Company Information Table 81. Crawford Wisdom International Business Overview Table 82. Crawford Wisdom International Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Crawford Wisdom International Enzymes for β-lactam Antibiotics Product Portfolio Table 84. Crawford Wisdom International Recent Development Table 85. Creative Enzymes Company Information Table 86. Creative Enzymes Business Overview Table 87. Creative Enzymes Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Creative Enzymes Enzymes for β-lactam Antibiotics Product Portfolio Table 89. Creative Enzymes Recent Development Table 90. Fermenta Biotech Ltd. Company Information Table 91. Fermenta Biotech Ltd. Business Overview Table 92. Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Product Portfolio Table 94. Fermenta Biotech Ltd. Recent Development Table 95. Merck & Co. Company Information Table 96. Merck & Co. Business Overview Table 97. Merck & Co. Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Merck & Co. Enzymes for β-lactam Antibiotics Product Portfolio Table 99. Merck & Co. Recent Development Table 100. MuseChem Chemicals Company Information Table 101. MuseChem Chemicals Business Overview Table 102. MuseChem Chemicals Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. MuseChem Chemicals Enzymes for β-lactam Antibiotics Product Portfolio Table 104. MuseChem Chemicals Recent Development Table 105. Biolab Company Information Table 106. Biolab Business Overview Table 107. Biolab Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Biolab Enzymes for β-lactam Antibiotics Product Portfolio Table 109. Biolab Recent Development Table 110. Hangzhou Chuangke Biotech Company Information Table 111. Hangzhou Chuangke Biotech Business Overview Table 112. Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Product Portfolio Table 114. Hangzhou Chuangke Biotech Recent Development Table 115. Hangzhou Junfeng Bioengineering Company Information Table 116. Hangzhou Junfeng Bioengineering Business Overview Table 117. Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Product Portfolio Table 119. Hangzhou Junfeng Bioengineering Recent Development Table 120. Hunan Fulaige Biotech Company Information Table 121. Hunan Fulaige Biotech Business Overview Table 122. Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Product Portfolio Table 124. Hunan Fulaige Biotech Recent Development Table 125. Shanghai Kekai Biotech Company Information Table 126. Shanghai Kekai Biotech Business Overview Table 127. Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Product Portfolio Table 129. Shanghai Kekai Biotech Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Enzymes for β-lactam Antibiotics Distributors List Table 133. Enzymes for β-lactam Antibiotics Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Enzymes for β-lactam Antibiotics Product Image Figure 2. Global Enzymes for β-lactam Antibiotics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzymes for β-lactam Antibiotics Market Size (2021-2032) & (US$ Million) Figure 4. Global Enzymes for β-lactam Antibiotics Sales (2021-2032) & (K Units) Figure 5. Global Enzymes for β-lactam Antibiotics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Enzymes for β-lactam Antibiotics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Penicillin Acylase Image Figure 9. β-lactamase Image Figure 10. Other Image Figure 11. Global Enzymes for β-lactam Antibiotics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Enzymes for β-lactam Antibiotics Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Enzymes for β-lactam Antibiotics Sales Market Share by Type (2021-2032) Figure 14. Global Enzymes for β-lactam Antibiotics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Enzymes for β-lactam Antibiotics Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Type (2021-2032) Figure 17. Cephalosporins Image Figure 18. Penicillin and Its Derivatives Image Figure 19. Monoamide Ring Image Figure 20. Other Image Figure 21. Global Enzymes for β-lactam Antibiotics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Enzymes for β-lactam Antibiotics Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Enzymes for β-lactam Antibiotics Sales Market Share by Application (2021-2032) Figure 24. Global Enzymes for β-lactam Antibiotics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Enzymes for β-lactam Antibiotics Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Application (2021-2032) Figure 27. North America Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Enzymes for β-lactam Antibiotics Sales Market Share by Country (2021-2032) Figure 29. U.S. Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Enzymes for β-lactam Antibiotics Sales Market Share by Country (2021-2032) Figure 34. Germany Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Enzymes for β-lactam Antibiotics Sales Market Share by Country (2021-2032) Figure 41. China Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Enzymes for β-lactam Antibiotics Sales Market Share by Country (2021-2032) Figure 49. Brazil Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Enzymes for β-lactam Antibiotics Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Enzymes for β-lactam Antibiotics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Enzymes for β-lactam Antibiotics Revenue (2021-2032) & (US$ Million) Figure 60. North America Enzymes for β-lactam Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Enzymes for β-lactam Antibiotics Revenue (2021-2032) & (US$ Million) Figure 62. Europe Enzymes for β-lactam Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Enzymes for β-lactam Antibiotics Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Enzymes for β-lactam Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Enzymes for β-lactam Antibiotics Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Enzymes for β-lactam Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Enzymes for β-lactam Antibiotics Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Enzymes for β-lactam Antibiotics Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Penicillin Acylase
  • β-lactamase
  • Other
Applications
  • Cephalosporins
  • Penicillin and Its Derivatives
  • Monoamide Ring
  • Other
Companies covered
  • MCE
  • Amicogen
  • Biosynth
  • Crawford Wisdom International
  • Creative Enzymes
  • Fermenta Biotech Ltd.
  • Merck & Co.
  • MuseChem Chemicals
  • Biolab
  • Hangzhou Chuangke Biotech
  • Hangzhou Junfeng Bioengineering
  • Hunan Fulaige Biotech
  • Shanghai Kekai Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Enzymes for β-lactam Antibiotics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Enzymes for β-lactam Antibiotics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Enzymes for β-lactam Antibiotics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Enzymes for β-lactam Antibiotics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Enzymes for β-lactam Antibiotics Market Dynamics
  1. 2.1 Enzymes for β-lactam Antibiotics Industry Trends
  2. 2.2 Enzymes for β-lactam Antibiotics Industry Drivers
  3. 2.3 Enzymes for β-lactam Antibiotics Industry Opportunities and Challenges
  4. 2.4 Enzymes for β-lactam Antibiotics Industry Restraints
3 Enzymes for β-lactam Antibiotics Market by Manufacturers
  1. 3.1 Global Enzymes for β-lactam Antibiotics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Enzymes for β-lactam Antibiotics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Enzymes for β-lactam Antibiotics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Enzymes for β-lactam Antibiotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Enzymes for β-lactam Antibiotics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Enzymes for β-lactam Antibiotics Manufacturers, Product Type & Application
  7. 3.7 Global Enzymes for β-lactam Antibiotics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Enzymes for β-lactam Antibiotics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Enzymes for β-lactam Antibiotics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Enzymes for β-lactam Antibiotics Tier 1, Tier 2, and Tier 3
4 Enzymes for β-lactam Antibiotics Market by Type
  1. 4.1 Enzymes for β-lactam Antibiotics Type Introduction
  2. 4.1.1 Penicillin Acylase
  3. 4.1.2 β-lactamase
  4. 4.1.3 Other
  5. 4.2 Global Enzymes for β-lactam Antibiotics Sales by Type
  6. 4.2.1 Global Enzymes for β-lactam Antibiotics Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Enzymes for β-lactam Antibiotics Sales by Type (2021-2032)
  8. 4.2.3 Global Enzymes for β-lactam Antibiotics Sales Market Share by Type (2021-2032)
  9. 4.3 Global Enzymes for β-lactam Antibiotics Revenue by Type
  10. 4.3.1 Global Enzymes for β-lactam Antibiotics Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Enzymes for β-lactam Antibiotics Revenue by Type (2021-2032)
  12. 4.3.3 Global Enzymes for β-lactam Antibiotics Revenue Market Share by Type (2021-2032)
5 Enzymes for β-lactam Antibiotics Market by Application
  1. 5.1 Enzymes for β-lactam Antibiotics Application Introduction
  2. 5.1.1 Cephalosporins
  3. 5.1.2 Penicillin and Its Derivatives
  4. 5.1.3 Monoamide Ring
  5. 5.1.4 Other
  6. 5.2 Global Enzymes for β-lactam Antibiotics Sales by Application
  7. 5.2.1 Global Enzymes for β-lactam Antibiotics Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Enzymes for β-lactam Antibiotics Sales by Application (2021-2032)
  9. 5.2.3 Global Enzymes for β-lactam Antibiotics Sales Market Share by Application (2021-2032)
  10. 5.3 Global Enzymes for β-lactam Antibiotics Revenue by Application
  11. 5.3.1 Global Enzymes for β-lactam Antibiotics Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Enzymes for β-lactam Antibiotics Revenue by Application (2021-2032)
  13. 5.3.3 Global Enzymes for β-lactam Antibiotics Revenue Market Share by Application (2021-2032)
6 Global Enzymes for β-lactam Antibiotics Sales by Region
  1. 6.1 Global Enzymes for β-lactam Antibiotics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enzymes for β-lactam Antibiotics Sales by Region (2021-2032)
  3. 6.2.1 Global Enzymes for β-lactam Antibiotics Sales by Region (2021-2026)
  4. 6.2.2 Global Enzymes for β-lactam Antibiotics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Enzymes for β-lactam Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Enzymes for β-lactam Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Enzymes for β-lactam Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Enzymes for β-lactam Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Enzymes for β-lactam Antibiotics Revenue by Region
  1. 7.1 Global Enzymes for β-lactam Antibiotics Revenue by Region
  2. 7.1.1 Global Enzymes for β-lactam Antibiotics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Enzymes for β-lactam Antibiotics Revenue by Region (2021-2026)
  4. 7.1.3 Global Enzymes for β-lactam Antibiotics Revenue by Region (2027-2032)
  5. 7.1.4 Global Enzymes for β-lactam Antibiotics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Enzymes for β-lactam Antibiotics Revenue (2021-2032)
  8. 7.2.2 North America Enzymes for β-lactam Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Enzymes for β-lactam Antibiotics Revenue (2021-2032)
  11. 7.3.2 Europe Enzymes for β-lactam Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Enzymes for β-lactam Antibiotics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Enzymes for β-lactam Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Enzymes for β-lactam Antibiotics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Enzymes for β-lactam Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 MCE
  2. 8.1.1 MCE Company Information
  3. 8.1.2 MCE Business Overview
  4. 8.1.3 MCE Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 MCE Enzymes for β-lactam Antibiotics Product Portfolio
  6. 8.1.5 MCE Recent Developments
  7. 8.2 Amicogen
  8. 8.2.1 Amicogen Company Information
  9. 8.2.2 Amicogen Business Overview
  10. 8.2.3 Amicogen Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amicogen Enzymes for β-lactam Antibiotics Product Portfolio
  12. 8.2.5 Amicogen Recent Developments
  13. 8.3 Biosynth
  14. 8.3.1 Biosynth Company Information
  15. 8.3.2 Biosynth Business Overview
  16. 8.3.3 Biosynth Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biosynth Enzymes for β-lactam Antibiotics Product Portfolio
  18. 8.3.5 Biosynth Recent Developments
  19. 8.4 Crawford Wisdom International
  20. 8.4.1 Crawford Wisdom International Company Information
  21. 8.4.2 Crawford Wisdom International Business Overview
  22. 8.4.3 Crawford Wisdom International Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Crawford Wisdom International Enzymes for β-lactam Antibiotics Product Portfolio
  24. 8.4.5 Crawford Wisdom International Recent Developments
  25. 8.5 Creative Enzymes
  26. 8.5.1 Creative Enzymes Company Information
  27. 8.5.2 Creative Enzymes Business Overview
  28. 8.5.3 Creative Enzymes Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Creative Enzymes Enzymes for β-lactam Antibiotics Product Portfolio
  30. 8.5.5 Creative Enzymes Recent Developments
  31. 8.6 Fermenta Biotech Ltd.
  32. 8.6.1 Fermenta Biotech Ltd. Company Information
  33. 8.6.2 Fermenta Biotech Ltd. Business Overview
  34. 8.6.3 Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Product Portfolio
  36. 8.6.5 Fermenta Biotech Ltd. Recent Developments
  37. 8.7 Merck & Co.
  38. 8.7.1 Merck & Co. Company Information
  39. 8.7.2 Merck & Co. Business Overview
  40. 8.7.3 Merck & Co. Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck & Co. Enzymes for β-lactam Antibiotics Product Portfolio
  42. 8.7.5 Merck & Co. Recent Developments
  43. 8.8 MuseChem Chemicals
  44. 8.8.1 MuseChem Chemicals Company Information
  45. 8.8.2 MuseChem Chemicals Business Overview
  46. 8.8.3 MuseChem Chemicals Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MuseChem Chemicals Enzymes for β-lactam Antibiotics Product Portfolio
  48. 8.8.5 MuseChem Chemicals Recent Developments
  49. 8.9 Biolab
  50. 8.9.1 Biolab Company Information
  51. 8.9.2 Biolab Business Overview
  52. 8.9.3 Biolab Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Biolab Enzymes for β-lactam Antibiotics Product Portfolio
  54. 8.9.5 Biolab Recent Developments
  55. 8.10 Hangzhou Chuangke Biotech
  56. 8.10.1 Hangzhou Chuangke Biotech Company Information
  57. 8.10.2 Hangzhou Chuangke Biotech Business Overview
  58. 8.10.3 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Product Portfolio
  60. 8.10.5 Hangzhou Chuangke Biotech Recent Developments
  61. 8.11 Hangzhou Junfeng Bioengineering
  62. 8.11.1 Hangzhou Junfeng Bioengineering Company Information
  63. 8.11.2 Hangzhou Junfeng Bioengineering Business Overview
  64. 8.11.3 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Product Portfolio
  66. 8.11.5 Hangzhou Junfeng Bioengineering Recent Developments
  67. 8.12 Hunan Fulaige Biotech
  68. 8.12.1 Hunan Fulaige Biotech Company Information
  69. 8.12.2 Hunan Fulaige Biotech Business Overview
  70. 8.12.3 Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Product Portfolio
  72. 8.12.5 Hunan Fulaige Biotech Recent Developments
  73. 8.13 Shanghai Kekai Biotech
  74. 8.13.1 Shanghai Kekai Biotech Company Information
  75. 8.13.2 Shanghai Kekai Biotech Business Overview
  76. 8.13.3 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Product Portfolio
  78. 8.13.5 Shanghai Kekai Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Enzymes for β-lactam Antibiotics Value Chain Analysis
  2. 9.1.1 Enzymes for β-lactam Antibiotics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Enzymes for β-lactam Antibiotics Production Mode & Process
  6. 9.2 Enzymes for β-lactam Antibiotics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Enzymes for β-lactam Antibiotics Distributors
  9. 9.2.3 Enzymes for β-lactam Antibiotics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research